Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial Meeting Abstract
| Authors: | Keohan, M. L.; Morgan, J. A.; D'Adamo, D. R.; Harmon, D.; Butrynski, J. E.; Wagner, A. J.; Schwartz, G. K.; Maki, R. G.; Demetri, G. D.; George, S. |
| Abstract Title: | Continuous daily dosing (CDD) of sunitinib (SU) in patients with metastatic soft tissue sarcomas (STS) other than GIST: Results of a phase II trial |
| Meeting Title: | 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2008 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2008-05-20 |
| Start Page: | 561s |
| Language: | English |
| ACCESSION: | WOS:000208457403761 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2008.26.15_suppl.10533 |
| Notes: | Meeting Abstract: 10533 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
